INTRODUCTION
Pregnancy is a normal physiological state that may accompany some common conditions which may occur normally due to the physiological changes for which drug treatment may be necessary. Sometimes certain chronic medical conditions like tuberculosis, diabetes etc. may occur during or before pregnancy which are needed to be treated for the benefits of both mother and foetus. However, most studies reporting the drug use during pregnancy found an increasing trend in drug use. 1 A pregnancy is defined as 'High risk' when there is a likelihood of an adverse outcome to the woman and/or to the baby that is greater than the incidence of that outcome in the general pregnant population. A high risk pregnancy is that with a significant probability for a poor maternal or foetal outcome. High risk patients require sophisticated maternal and foetal surveillance and in many occasions difficult management. A high risk pregnancy can be identified only if the woman has access to prenatal care.
List of conditions that place pregnancy at high risk are such as anaemia, hypertension, diabetes, cardiac disease, multiple pregnancies, oligohydramnios, intra uterine growth retardation, ante partum haemorrhage, eclampsia, post dates pregnancy, human immune deficiency virus infection, asthma and others. 2 Drugs play an important role in improving human health and promoting well being. However to produce the desired effect, they have Department of Pharmacology, Smt. N.H.L. Municipal Medical College, Ellisbridge, Ahmedabad-380006, India to be safe, efficacious and have to be used rationally. Safe and efficacious use of drugs prevents morbidity and mortality in mother and foetus. Hence, our objective of the study was to study the morbidity pattern, drug use pattern in indoor patients of high risk pregnancy at Obstetrics and Gynaecology department in a tertiary care teaching hospital; to evaluate the drug use pattern Using US-FDA Drug Risk Category 3 , WHO core drug prescribing indicators 4 and to find out the average cost of treatment per patient.
METHODS
The present study was carried out in obstetrics and gynecology department at a tertiary care teaching hospital in Ahmedabad, India during 6 months period from January 2012 to June 2012. All the patients admitted to obstetrics department were included in our study. The protocol and other documents like proforma, patient information sheet and informed consent form in English and Gujarati were approved by Institutional Review Board (IRB). The study was started after getting written approval from IRB.
The data was collected from all the patients irrespective of age in a pre-designed proforma after taking written informed consent from the patients and/or patient's relatives. The proforma includes patient's demographic details, religion, indoor number, pregnancy duration, provisional diagnosis / chief complaints, investigations and complete prescription. Data of all the 250 patients were analysed by using SPSS version 20.0 Software. Prescription pattern was evaluated by using WHO core drug prescribing indicators and US-FDA Drug Risk Category.
RESULTS
The demographic data concerning the age of the study population shows that out of total 250 pregnant women, 19 (7.6%), 218 (87.2%) and 13 (5.2%) were of less than 20, 20 to 30 and more than 30 years of age respectively ( Figure 1) (Figure 4 ). Note-One patient may have more than one disease.
APH-Antepartum haemorrhage. IUGR-Intrauterine Growth Retardation
In the first trimester folic acid (87.5%) was most frequently prescribed followed by ant emetic drug (25%), iron (75%), protein powder (75%), paracetamol (50%) and antimicrobial drugs (25%). In the second trimester iron (91.0%), calcium (89.0%) and folic acid (84.9%) commonly used followed by protein powder (77.3%), vitamin C (74.8%), nifedipine (41.2%), isoxsuprine (33.6%), antifungal drug (27.7%), antimicrobial agents (15.9%), antacids (14.3%) and insulin (6.7%). In the third trimester iron (89.4%), calcium (86.1%), and folic acid (50.0%) were most frequently prescribed followed by protein powder (31.7%), vitamin C (22.7%), isoxsuprine (20.3%), nifedipine (15.4%), essential amino acids (12.2%), antifungal drugs (9.8%) and betamethasone (9.8%) ( Table 3) . Out of 119 patients of anaemia, 82 (32.8%) and 37 (14.8%) patients suffered from moderate anaemia (Hb-7 to 10 gm %) and severe (Hb-< 7gm %) respectively. In moderate anaemia, iron salts were given in most of patients as to overcome the need of increased iron requirement during pregnancy. Ferrous fumarate and ferrous ascorbate were the most commonly used iron salts. Ferrous fumarate and Ferrous ascorbate was prescribed to 65 (80.0%) and 14 (20.0%) patients in the dose of 300 mg and 100 mg once or twice a day respectively according to haemoglobin. Iron sucrose was given to 15 (6%) patients. After dilution in normal saline, it was given intravenously slowly. In moderate and severe anaemia 3 and 10 patients were prescribed iron sucrose injection respectively. In severe anaemia, packed cell volume (PCV) was given to 27 (10.8%) patients. After each Packed Cell Volume (PCV), injection furosemide (40 mg) was given intravenously.
In PIH patients, nifedipine was given to 60 (24.0%) patients. It was given in 10 mg orally twice or thrice a day according to blood pressure. Labetalol was prescribed to 42 (16.8%) patients. Most of patients were given 100 mg twice a day orally and dose was adjusted according to blood pressure. Methyldopa had been given to 32 (12.8%) patients with dose of 250 mg twice or thrice a day according to blood pressure. Magnesium sulphate was prescribed to 10 (4%) patients who had severe or impending eclampsia, with a dose of 4 gm I.V. diluted in 12 ml normal saline and 10 gm intramuscular with 5 gm in each buttock. Essential amino acids like linoleic acid and linolenic acid were given orally daily to 15 (6%) patients of oligohydramnios. Arginine sachet contains arginine amino acid was prescribed to 11 (6%) patients orally once a day according to severity of oligohydramnios. Out of 12(4.8%) patients of diabetes, insulin was given subcutaneously according to blood sugar and diabetic profile. Combination of short and intermediate acting insulin (soluble + isophane insulin (30/70)) was given. Two thirds of dose was given before breakfast and a third before dinner. 9(3.6%) patients were diagnosed IUGR. Essential amino acids like linoleic acid and linolenic acid were given orally daily to 4 patients. Arginine sachet was prescribed to 5 patients orally once a day according to severity of IUGR. Hermin (Brand Name) injection (500ml) contains combination of various amino acids was also given to 2 patients intravenously alternate day. Cost of total duration of drug therapy per patient was 303.2 (±30.96) INR (Indian Rupees).
In the present study majority of drugs were from category A 82.21% which is the safest category followed by category B 15.64% category C 2.15% and category D 0.00% ( Figure 5 ). World Health Organization (WHO) has given three types of indicators namely prescribing indicators, patient care indicators and facility indicators as determinant of rational prescribing. Out of this, in the present study, only prescribing indicators has been used. (Table 4) . 
DISCUSSION
In the present study, the demographic data demonstrated that baseline study population was comparable to earlier study done in Kathmandu in which 90% of women were under 30 years of age. 5 But it is not in accordance with the study carried out in Australia showed women less than 20, 20 to 30 and more than 30 years of age were 4%, 70% and 26% respectively. 6 Trimester wise distribution of the study population is similar with previous study 5 in which most of patients were in second trimester. Disease pattern is not in accordance with study done in Mexico in which preeclampsia, postpartum haemorrhage, and chronic hypertension were common. 7 Morbidity pattern is in accordance with studies done in Bangladesh 8 and Netherlands 9 but different than one study. 10 Repeated pregnancy is also contributing factor for poor nutritional status of the mother. All these factors deplete the micronutrient stores of the mother, to the extent that she becomes anaemic even in the first trimester. This brings adverse outcome for mother and foetus. 11, 12 Hence in our study iron, calcium, and protein powder were given to 91.2%, 84.5%, and 54.8% patients (Figure 4) . Preconception folic acid supplementation can prevent neural tube defects and other congenital abnormalities of the cardiovascular system, urinary tract and limb deficiencies of foetus. 13 So folic acid was prescribed to 59.6% patients. Vitamin C increases the absorption of iron from non-animal foods such as spinach and also plays a role in the storage of iron in major organs like liver.
14 Vitamin C therefore aids the body in the efficient use of folic acid and iron. 15 Vitamin C was prescribed to 46.8% patients in our study.
Iron deficiency is one of the most common nutritional disorders in developing countries. 16 It is an important preventable cause of maternal and perinatal morbidity and mortality. Common complaints were weakness, fatigue, dyspnea and headache. A much higher incidence of anemia (47.6%) is recorded in present study which is in accordance with study done in Bangladesh (49%). 17 It is less than one study done in Uganda (84.4%) 18 but more than one study done in Pakistan (40%). 19 In moderate anemia, iron salts were given in most of patients as to overcome the need of increased iron requirement during pregnancy. Ferrous fumarate and Ferrous ascorbate was prescribed in 144 (57.6%) and 45 (18%) patients which is similar to other studies in United States (72%) 19 , Switzerland (65%) 20 , West Nepal (72.8%) 21 and Egypt (86%) 22 But less than one study. 23 Injectable iron like iron sucrose was prescribed to moderate and severe anemia when oral iron was not tolerated and gives faster response. Intravenous PCV was given to patients of severe anemia in late pregnancy.
In PIH, the most commonly prescribed antihypertensive agents were given alone or in combination with nifedipine (24.4%), labetalol (16.8%) and methyldopa (12.8%). These are different than previous study in which methyldopa was most commonly prescribed followed by nifedipine and hydralazine. 24 Magnesium sulphate was given to those patients, which were suffering from eclampsia. This is similar with previous study done in Egypt. 25 Wherever needed, a combination of drugs was used for better reduction in blood pressure. This improves patient compliance and decreases PIH with fewer adverse events. 26 Oligohydramnios has also been treated with amino acids infusion. 27 The treatment course involved daily infusions of amino acid solution with/without 10% glucose. Daily intravascular foetal nutrition may significantly improve both foetal condition and foetal weight gain in oligohydramnios. 28 Cost of total duration of drug therapy per patient was 303.2 (±30.96) INR (Indian Rupees). As less (32%) number of drugs prescribed from hospital supply, average cost of therapy is high. Now a days metformin and glyburide used for treatment of gestational diabetes, but high numbers of patients need to discontinue and switch over to insulin. 29, 30 In our study insulin was given to all patients of gestational diabetes. As per guidelines, insulin combination of short and intermediate acting insulin was used in 12 patients. Comparing the drug risk categories for pregnancy, introduced by US food and drug administration (FDA), in the present study majority of drugs were from category A 82.21% which is the safest category followed by category B 15.64% category C 2.15% and category D 0.00%. No drug were prescribed from category X which are absolutely contraindicated in pregnancy ( Figure 5 ). The similar pattern of category distribution was seen in the study done in Netherland in which from category A 81.7% category B 10.9%, category C 6.3% category D 1.1%, category X 0.0%. 31 There are reports of use of potentially harmful drug from category X drug during pregnancy from other developed and underdeveloped countries of the world. 32 In a retrospective, register based cohort study in Finland, it was found that 20.4% of women purchased at least one drug classified as potentially harmful during pregnancy and 3.4% purchased at least one drug classified as clearly harmful. 33 In a study from Bratislava and Nitra, it was reported that a vast majority of prescribed drugs during pregnancy, belonged to category C. 34 So from the above data we can say that the prescription habit in our set up is quite safe.
Percentage of drugs prescribed by generic name is 62.80%. This shows a greater tendency to prescribe by generic name rather than by brand name. Most of the patients attending the teaching hospitals belong to the lower socio economic classes, so tendency to prescribe by generic name may influence the compliance of patients by affecting the cost. Percentage of encounters with antibiotic prescribed is 13.20% mainly due to respiratory tract infection during pregnancy. Amoxicillin is used in such conditions. Percentage of encounters with an injection prescribed 25.29%. Injectable preparations are used for anaemia, eclampsia, oligohydramnios and IUGR. Percentage of drugs prescribed from essential drugs list is 80.79%. As high rates of drugs prescribe from essential drugs list, it suggests rationality of drug use pattern. Percentage of drugs prescribed from hospital drug list is 32.50%. So more than 60% of drugs were prescribed from outside the hospital. The reason may be unavailability of the necessary drugs in hospital pharmacy or greater influence of the pharmaceutical companies on the prescriber. It may increase the overall cost of drug therapy.
CONCLUSION
Abdominal pain and weakness were commonest complaints. Disease pattern showed that anaemia and PIH were commonest. Overall prescribing habit in this set-up is appropriate and rational to a large extent. But there is lesser number of drugs prescribed by generic name suggesting need for sincere efforts to improve situation. This is the preliminary study and further studies are required to find out broader evaluation of the hypolipidemic agents. Hence, such periodic studies are further required in diverse environment, social, educational and cultural conditions, so that the therapeutic guidelines could be revised accordingly to give proper care to the community.
